US6429207B1
(en)
|
1997-11-21 |
2002-08-06 |
Nps Pharmaceuticals, Inc. |
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
|
EP1408980A4
(en)
|
2001-06-21 |
2004-10-20 |
Ariad Pharma Inc |
Novel quinazolines and uses thereof
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
US6924285B2
(en)
|
2002-03-30 |
2005-08-02 |
Boehringer Ingelheim Pharma Gmbh & Co. |
Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
|
JPWO2003104230A1
(en)
|
2002-06-07 |
2005-10-06 |
協和醗酵工業株式会社 |
Bicyclic pyrimidine derivatives
|
US7423044B2
(en)
|
2002-09-05 |
2008-09-09 |
Wyeth |
Pyrimidine derivatives useful in the treatment of insulin resistance and hyperglycemia
|
AR044743A1
(en)
*
|
2002-09-26 |
2005-10-05 |
Nihon Nohyaku Co Ltd |
HERBICIDE, METHOD OF USE, DERIVED FROM REPLACED TIENOPIRIMIDINE, INTERMEDIATE COMPOUNDS, AND PROCEDURES USED TO PRODUCE THEM,
|
US7196106B2
(en)
|
2002-11-05 |
2007-03-27 |
Merck & Co., Inc |
Cyanothiophene derivatives, compositions containing such compounds and methods of use
|
JP3988830B2
(en)
*
|
2002-11-22 |
2007-10-10 |
日本たばこ産業株式会社 |
Fused bicyclic nitrogen-containing heterocycle
|
EP1571146A4
(en)
*
|
2002-12-10 |
2010-09-01 |
Ono Pharmaceutical Co |
Nitrogen-containing heterocyclic compounds and medicinal use thereof
|
EP1620105B1
(en)
|
2003-04-16 |
2007-01-10 |
F. Hoffmann-La Roche Ag |
(6-(phenoxy)-pyrido¬3,4-d|pyrimidin-2-yl)-amine derivatives as p38 kinase inhibitors for the treatment of inflammatory conditions such as rheumatoid arthritis
|
JP2006523638A
(en)
|
2003-04-16 |
2006-10-19 |
エフ.ホフマン−ラ ロシュ アーゲー |
Quinazoline compounds
|
JP2007501801A
(en)
|
2003-08-07 |
2007-02-01 |
日本たばこ産業株式会社 |
Pyrrolo [1,2-b] pyridazine derivatives
|
WO2005016925A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Pfizer Limited |
Azaquinazoline derivatives
|
TW200530235A
(en)
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
US20070197510A1
(en)
*
|
2004-03-10 |
2007-08-23 |
Kazuyuki Ohmoto |
Nitriles and medicinal compositions containing the same as the active ingredient
|
US7793137B2
(en)
|
2004-10-07 |
2010-09-07 |
Cisco Technology, Inc. |
Redundant power and data in a wired data telecommunincations network
|
US7598259B2
(en)
|
2004-06-15 |
2009-10-06 |
Schering Corporation |
mGluR1 antagonists as therapeutic agents
|
PE20060526A1
(en)
|
2004-06-15 |
2006-07-13 |
Schering Corp |
TRICYCLE COMPOUNDS AS ANTAGONISTS OF MGLUR1
|
SG156650A1
(en)
|
2004-07-16 |
2009-11-26 |
Sunesis Pharmaceuticals Inc |
Thienopyrimidines useful as aurora kinase inhibitors
|
ATE435214T1
(en)
*
|
2004-09-02 |
2009-07-15 |
Vertex Pharma |
CHINAZOLINES SUITABLE AS ION CHANNEL MODULATORS
|
US7928107B2
(en)
|
2004-09-02 |
2011-04-19 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
US8283354B2
(en)
|
2004-09-02 |
2012-10-09 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
GB0420719D0
(en)
*
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
US20060128710A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
US7745451B2
(en)
|
2005-05-04 |
2010-06-29 |
Renovis, Inc. |
Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and dysfunctions
|
US7825244B2
(en)
|
2005-06-10 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
|
US8071768B2
(en)
|
2005-06-10 |
2011-12-06 |
Janssen Pharmaceutica, N.V. |
Alkylquinoline and alkylquinazoline kinase modulators
|
US7915410B2
(en)
*
|
2005-09-09 |
2011-03-29 |
Bristol-Myers Squibb Company |
Acyclic IKur inhibitors
|
CA2633035C
(en)
|
2005-12-15 |
2016-05-10 |
Rigel Pharmaceuticals, Inc. |
Kinase inhibitors and their uses
|
HUP0501168A3
(en)
*
|
2005-12-20 |
2007-10-29 |
Richter Gedeon Nyrt |
2-(acyl, oxycarbonyl or aminocarbonyl)-3-phenyl-thieno[2,3-b]pyridines, process for their preparation, their use and pharmaceutical composition containing them
|
KR20080087099A
(en)
*
|
2005-12-20 |
2008-09-30 |
리히터 게데온 닐트. |
New compounds
|
HUP0501170A2
(en)
*
|
2005-12-20 |
2007-09-28 |
Richter Gedeon Nyrt |
2-heteroaryl-3-phenyl-thieno[2,3-b]pyridines, process for their preparation, their use and pharmaceutical compositions containing them
|
CA2630896A1
(en)
*
|
2005-12-20 |
2007-06-28 |
Richter Gedeon Nyrt. |
New compounds
|
EP2345652A1
(en)
|
2005-12-21 |
2011-07-20 |
Abbott Laboratories |
Antiviral compounds
|
US7910595B2
(en)
|
2005-12-21 |
2011-03-22 |
Abbott Laboratories |
Anti-viral compounds
|
WO2007081517A2
(en)
|
2005-12-21 |
2007-07-19 |
Abbott Laboratories |
Anti-viral compounds
|
ATE475660T1
(en)
|
2005-12-21 |
2010-08-15 |
Abbott Lab |
ANTIVIRAL COMPOUNDS
|
TWI417095B
(en)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
|
DE102006012251A1
(en)
*
|
2006-03-15 |
2007-11-08 |
Grünenthal GmbH |
Substituted 4-aminoquinazoline derivatives and their use for the preparation of medicaments
|
EP1921070A1
(en)
|
2006-11-10 |
2008-05-14 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation
|
PL2083811T3
(en)
|
2006-11-22 |
2017-05-31 |
Clinical Research Associates, Llc |
Methods of treating down's syndrome, fragile x syndrome and autism
|
WO2008133753A2
(en)
|
2006-12-20 |
2008-11-06 |
Abbott Laboratories |
Anti-viral compounds
|
AU2008212999A1
(en)
|
2007-02-06 |
2008-08-14 |
Boehringer Ingelheim International Gmbh |
Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
WO2008157500A1
(en)
*
|
2007-06-17 |
2008-12-24 |
Kalypsys, Inc. |
Aminoquinazoline cannabinoid receptor modulators for treatment of disease
|
EP2178858B1
(en)
|
2007-08-02 |
2011-12-28 |
Recordati Ireland Limited |
Novel heterocyclic compounds as mglu5 antagonists
|
AU2008297876B2
(en)
|
2007-09-14 |
2011-07-07 |
Addex Pharma S.A. |
1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
|
JP5133416B2
(en)
|
2007-09-14 |
2013-01-30 |
オルソー−マクニール−ジャンセン ファーマシューティカルズ, インコーポレイテッド. |
1 ', 3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H, 1'H- [1,4'] bipyridinyl-2'-one
|
CA2711582A1
(en)
|
2008-02-07 |
2009-08-13 |
Boehringer Ingelheim International Gmbh |
Spirocyclic heterocycles, formulations containing said compounds, use thereof and processes for the preparation thereof
|
JP5739802B2
(en)
|
2008-05-13 |
2015-06-24 |
アストラゼネカ アクチボラグ |
4- (3-Chloro-2-fluoroanilino) -7-methoxy-6-{[1- (N-methylcarbamoylmethyl) piperidin-4-yl] oxy} quinazoline fumarate
|
JP5539351B2
(en)
|
2008-08-08 |
2014-07-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cyclohexyloxy-substituted heterocycles, medicaments containing these compounds, and methods for producing them
|
EP2344470B1
(en)
|
2008-09-02 |
2013-11-06 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
US8759362B2
(en)
*
|
2008-10-24 |
2014-06-24 |
Purdue Pharma L.P. |
Bicycloheteroaryl compounds and their use as TRPV1 ligands
|
CA2744343A1
(en)
*
|
2008-11-19 |
2010-05-27 |
Renovis, Inc. |
6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine compounds useful as faah modulators and uses thereof
|
CN102232074B
(en)
|
2008-11-28 |
2014-12-03 |
奥梅-杨森制药有限公司 |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
PL2364314T3
(en)
*
|
2008-12-09 |
2014-08-29 |
Gilead Sciences Inc |
Modulators of toll-like receptors
|
EP2393780A1
(en)
|
2009-02-04 |
2011-12-14 |
Recordati Ireland Limited |
Heterocyclic derivatives as m-glu5 antagonists
|
BRPI1010831A2
(en)
|
2009-05-12 |
2016-04-05 |
Addex Pharmaceuticals Sa |
1,2,4-triazolo [4,3-a] pyridine derivatives and their as positive allosteric modulators of mglur2 receptors
|
RS53075B
(en)
|
2009-05-12 |
2014-04-30 |
Janssen Pharmaceuticals Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
EP2477981A1
(en)
|
2009-09-14 |
2012-07-25 |
Recordati Ireland Limited |
Heterocyclic mglu5 antagonists
|
WO2011106276A1
(en)
*
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Task channel antagonists
|
EP2544688B1
(en)
|
2010-03-02 |
2016-09-07 |
President and Fellows of Harvard College |
Methods and compositions for treatment of angelman syndrome
|
US20110294879A1
(en)
|
2010-05-28 |
2011-12-01 |
Xenoport, Inc. |
Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders
|
CN103097391B
(en)
*
|
2010-07-09 |
2015-04-08 |
雷科尔达蒂爱尔兰有限公司 |
Novel spiroheterocyclic compounds as mGlu5 antagonists
|
US20120016021A1
(en)
|
2010-07-15 |
2012-01-19 |
Xenoport, Inc. |
Methods of treating fragile x syndrome, down's syndrome, autism and related disorders
|
TW201219398A
(en)
|
2010-10-08 |
2012-05-16 |
Abbott Lab |
Furo[3,2-d]pyrimidine compounds
|
WO2012054724A1
(en)
|
2010-10-21 |
2012-04-26 |
Massachusetts Institute Of Technology |
Methods of treating seizure disorders
|
AU2011328195B2
(en)
|
2010-11-08 |
2015-04-02 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
PT2649069E
(en)
|
2010-11-08 |
2015-11-20 |
Janssen Pharmaceuticals Inc |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
CA2815002C
(en)
|
2010-11-08 |
2019-10-22 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
US9034885B2
(en)
|
2012-01-13 |
2015-05-19 |
Acea Biosciences Inc. |
EGFR modulators and uses thereof
|
US9464089B2
(en)
|
2012-01-13 |
2016-10-11 |
Acea Biosciences Inc. |
Heterocyclic compounds and uses thereof
|
EP2802568A1
(en)
|
2012-01-13 |
2014-11-19 |
Acea Biosciences, Inc. |
Heterocyclic compounds and uses as anticancer agents.
|
US9586965B2
(en)
|
2012-01-13 |
2017-03-07 |
Acea Biosciences Inc. |
Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases
|
TWI499591B
(en)
|
2013-01-11 |
2015-09-11 |
Lilly Co Eli |
Bicyclic pyrimidine compounds
|
TW201520219A
(en)
*
|
2013-03-12 |
2015-06-01 |
Lilly Co Eli |
Imidazo pyridine compounds
|
TW201500356A
(en)
*
|
2013-04-12 |
2015-01-01 |
Lilly Co Eli |
Dihydropyrido pyrimidine compounds
|
JO3368B1
(en)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
JP6564771B2
(en)
|
2013-07-11 |
2019-08-21 |
エイシア バイオサイエンシーズ インコーポレイテッド |
Pyrimidine derivatives as kinase inhibitors
|
JO3367B1
(en)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
IL279202B2
(en)
|
2014-01-21 |
2023-09-01 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
KR20220051273A
(en)
|
2014-01-21 |
2022-04-26 |
얀센 파마슈티카 엔.브이. |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
US9868744B2
(en)
|
2014-04-25 |
2018-01-16 |
Pfizer Inc. |
Heteroaromatic compounds and their use as dopamine D1 ligands
|
WO2017004405A1
(en)
*
|
2015-07-01 |
2017-01-05 |
Northwestern University |
Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity
|
CN108368127B
(en)
|
2015-07-23 |
2020-12-11 |
武田药品工业株式会社 |
Compounds and their use as EP4 receptor antagonists
|
CN107949388B
(en)
|
2015-10-09 |
2021-10-26 |
艾森医药公司 |
Pharmaceutical salts, physical forms and compositions of pyrrolopyrimidine kinase inhibitors and methods of making the same
|
GB201700814D0
(en)
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
CA3059072A1
(en)
|
2017-04-07 |
2018-10-11 |
ACEA Therapeutics, Inc. |
Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same
|
JP7235184B1
(en)
*
|
2021-04-26 |
2023-03-08 |
三菱瓦斯化学株式会社 |
Compound and its manufacturing method
|